Loading company…
OncoDiag develops laboratory tests for detecting and monitoring cancers.
Founded in 2013 and based in France, OncoDiag develops cancer diagnostic tests, including Urodiag® for bladder cancer surveillance, Prostadiag® for localized prostate cancer, and Colodiag® for colorectal cancer screening. Its clients include hospitals, diagnostic laboratories, and healthcare providers. In March 2021, the company raised EUR 1 mn in venture debt from Bpifrance and Normandie Participations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in